IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 333 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets
Muzna Sadia,Abdullah Isreb,Ibrahim Abbadi,Mohammad Isreb,David Aziz,Amjad Selo,Peter Timmins,Mohamed A. Alhnan
European Journal of Pharmaceutical Sciences.2018;123()484
[DOI]
2Identification of At-risk Pregnant Population for Over-the-Counter Drug Usage in Low-Resource Settings
Aashima Arora,M. Praveen Kumar,Aishwarya Anand,Lekha Saha,Pradip Kumar Saha,Ankit Kumar,Haresh Shendge,Amol N. Patil
The Journal of Obstetrics and Gynecology of India.2021;71(6)600
[DOI]
3Availability, Prices and Affordability of Antibiotics Stocked by Informal Providers in Rural India: A Cross-Sectional Survey
Meenakshi Gautham,Rosalind Miller,Sonia Rego,Catherine Goodman
Antibiotics.2022;11(4)523
[DOI]
4Improving access to medicines by popularising generics: a study of ‘India’s People’s Medicine’ scheme in two districts of Maharashtra
Sonam Lavtepatil,Soumitra Ghosh
BMC Health Services Research.2022;22(1)523
[DOI]
5Fixed-dose combinations banned in India: is it the right decision? An eye-opening review
Marlon Ramcy Henry Miranda,Akhilesh Dubey,Ravi G.S,R Narayana Charyulu
Expert Opinion on Drug Safety.2019;18(10)977
[DOI]
6Communication with Physicians: a Tool for Improving Appropriate Antibiotic Use in the Absence of Regulatory Mechanisms
Purabi Barman,Tarun Thukral,Shimpi Chopra
Current Treatment Options in Infectious Diseases.2021;13(1)1
[DOI]
7Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination
Vikas Rathee,Kapil Pihwal,Neelam Pawar,Sheikh Aamir,Mohammad S. Alam,Kavita Bahmani
Applied Drug Research, Clinical Trials and Regulatory Affairs.2021;8(1)19
[DOI]
8Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge
Nikhil Bush,Vishal Sharma,K Chandrahasan,AmolN Patil
Journal of Family Medicine and Primary Care.2020;9(6)3157
[DOI]
9Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Brian Godman,Holly McCabe,Trudy D Leong,Debjani Mueller,Antony P. Martin,Iris Hoxha,Julius C. Mwita,Godfrey Mutashambara Rwegerera,Amos Massele,Juliana de Oliveira Costa,Renata Cristina Rezende Macedo do Nascimento,Livia Lovato Pires de Lemos,Konstantin Tachkov,Petya Milushewa,Okwen Patrick,Loveline Lum Niba,Ott Laius,Israel Sefah,Suhaj Abdulsalim,Fatemeh Soleymani,Anastasia N Guantai,Loice Achieng,Margaret Oluka,Arianit Jakupi,Konstantins Logviss,Mohamed Azmi Hassali,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph Fadare,Olayinka O. Ogunleye,Zikria Saleem,Shazhad Hussain,Tomasz Bochenek,Ileana Mardare,Alian A. Alrasheedy,Jurij Furst,Dominik Tomek,Vanda Markovic-Pekovic,Enos M. Rampamba,Abubakr Alfadl,Adefolarin A Amu,Zinhle Matsebula,Thuy Nguyen Thi Phuong,Binh Nguyen Thanh,Aubrey Chichonyi Kalungia,Trust Zaranyika,Nyasha Masuka,Ioana D. Olaru,Janney Wale,Ruaraidh Hill,Amanj Kurdi,Angela Timoney,Stephen Campbell,Johanna C. Meyer
Expert Review of Pharmacoeconomics & Outcomes Research.2020;20(1)1
[DOI]
10Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i?+?DPP4i in the Indian Diabetes Setting
Manoj Chadha,Ashok Kumar Das,Prasun Deb,Kalyan Kumar Gangopadhyay,Shashank Joshi,Jothydev Kesavadev,Rajiv Kovil,Surender Kumar,Anoop Misra,Viswanathan Mohan
Diabetes Therapy.2022;13(5)1097
[DOI]
11Fixed Dose Combinations in Indian Medicine Market - A SWOT Analysis
Revikumar KG
MOJ Bioequivalence & Bioavailability.2017;4(3)1097
[DOI]
12Assessment of utilization pattern of fixed dose drug combinations in primary, secondary and tertiary healthcare centers in Nepal: a cross-sectional study
Arjun Poudel,Mohamed Izham Mohamed Ibrahim,Pranaya Mishra,Subish Palaian
BMC Pharmacology and Toxicology.2017;18(1)1097
[DOI]
13Assessment of utilization pattern of fixed dose drug combinations in primary, secondary and tertiary healthcare centers in Nepal: a cross-sectional study
Subish Palaian
BMC Pharmacology and Toxicology.2018;18(1)145
[DOI]
14Fixed-dose combinations: An essential for rational preparation
Pugazhenthan Thangaraju,ShobanBabu Varthya,Sajitha Venkatesan
Indian Journal of Pharmacology.2021;53(2)170
[DOI]
15Emergence of recalcitrant dermatophytosis in India
Shyam B Verma
The Lancet Infectious Diseases.2018;18(7)718
[DOI]
16Developing a latent class analysis model to identify at-risk populations among people using medicine without prescription
Praveen Kumar-M,Rahul Mahajan,S Kathirvel,Naveen Hegde,Ashish Kumar Kakkar,Amol N. Patil
Expert Review of Clinical Pharmacology.2020;13(12)1411
[DOI]
17Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel
Sanjay Kalra,AK Das,G Priya,S Ghosh,RN Mehrotra,S Das,P Shah,S Bajaj,V Deshmukh,D Sanyal,S Chandrasekaran,D Khandelwal,A Joshi,T Nair,F Eliana,H Permana,MD Fariduddin,PK Shrestha,D Shrestha,S Kahandawa,M Sumanathilaka,A Shaheed,AA Rahim,A Orabi,A Al-ani,W Hussein,D Kumar,K Shaikh
Journal of Family Medicine and Primary Care.2020;9(11)5450
[DOI]
18Importance of patents and data exclusivity in fixed-dose combination medicinal products
Marija Mitkovska,Katerina Anchevska Netkovska,Aleksandra Grozdanova,Ana Poceva Panovska,Ema Kikovska Stojanovska
Macedonian Pharmaceutical Bulletin.2019;65(2)33
[DOI]
19Antibiotic Use and Misuse in Dentistry in India—A Systematic Review
Aarthi Bhuvaraghan,Rebecca King,Harriet Larvin,Vishal R. Aggarwal
Antibiotics.2021;10(12)1459
[DOI]
20Pharmaceutical Market and Drug Price Policy in India
Venkatanarayana Motkuri,Rudra Narayan Mishra
Review of Development and Change.2020;25(1)30
[DOI]
21Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status
Virendra S. Ligade,Tanmay M. Thakar,Swapnil J. Dengale
Tropical Medicine & International Health.2019;24(2)238
[DOI]
22Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status
Abialbon Paul
Tropical Medicine & International Health.2019;24(2)307
[DOI]
23Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
Ion G. Motofei,David L. Rowland,Mirela Manea,Simona R. Georgescu,Ioana Paunica,Ioanel Sinescu
Clinical Drug Investigation.2017;37(6)511
[DOI]
24Unorthodox Parenteral ß-Lactam and ß-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care
Snehal Palwe,Balaji Veeraraghavan,Hariharan Periasamy,Kshama Khobragade,Arun S. Kharat
Antimicrobial Agents and Chemotherapy.2020;64(5)511
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow